NCT04609696 - Study of the Metabolism of Danicopan in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

December 7, 2020

Study Completion Date

December 7, 2020

Conditions

Healthy

Interventions

DRUG

Danicopan: Powder-In-Capsule 1

Danicopan (200 milligrams) will be administered orally on Day 1.

DRUG

Danicopan: Powder-In-Capsule 2

Danicopan (200 milligrams) will be administered orally on Day 1.

DRUG

Danicopan: Tablet

Danicopan (200 milligrams) will be administered orally on Day 1.

Trial Locations (1)

Clinical Trial Site, Tempe